Catherine O. Stehman-Breen, MD, WIN Faculty
Catherine Stehman-Breen, MD received her medical degree from University of Chicago in 1990. She completed her residency and fellowship training at the University of Washington where she also received a Masters of Science degree in Epidemiology. She spent six years as a Faculty member in the Division of Nephrology at University of Washington. Her primary responsibilities included managing the Clinical Research Training Program and the development of the Epidemiology and Clinical Trials Research Program. Her research focused on bone and cardiovascular disease in renal disease patients. Catherine joined Amgen in 2003 where she became the Global Development Leader for Aranesp and Epogen. She became the Therapeutic Area Head for Bone, Nephrology and Neuroscience and was responsible for clinical programs related to bone loss, nephrology and several neuroscience indications. In 2015, she became the therapeutic area head for pain at Regeneron Pharmaceuticals. She is now the head of Clinical Operations.